Evidence map›Paper›PMID 25070895›Full record

ArticleThe Journal of biological chemistry2014

Mitochondria are gate-keepers of T cell function by producing the ATP that drives purinergic signaling.

Carola Ledderose, Yi Bao, Markus Lidicky, Johannes Zipperle, Linglin Li, Katharina Strasser, Nathan I Shapiro, Wolfgang G Junger

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 100 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Mitochondrial Regulation of CD8⁺ T Cells: Mechanisms and Therapeutic Modulation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Time-resolved role of P2X4 and P2X7 during CD8Frontiers in immunology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Augmented T-cell mitochondrial reactive oxygen species in adults with major depressive disorder.American journal of physiology. Heart and circulatory physiology · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Carola LedderoseFrom the Departments of Surgery and.
Yi BaoFrom the Departments of Surgery and.
Markus LidickyFrom the Departments of Surgery and Paracelsus Medical University, Salzburg, A-5020, Austria, and.
Johannes ZipperleFrom the Departments of Surgery and.
Linglin LiFrom the Departments of Surgery and.
Katharina StrasserFrom the Departments of Surgery and.
Nathan I ShapiroEmergency Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215.
Wolfgang G JungerFrom the Departments of Surgery and the Ludwig Boltzmann Institute for Traumatology, Vienna, A-1200, Austria wjunger@bidmc.harvard.edu.
Harvard University · USBeth Israel Deaconess Medical Center · USLudwig Boltzmann Institute for Digital Health and Prevention

Funding

Neutrophil activation and traumaR01GM060475 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JUNGER, WOLFGANG G · 2001 to 2016
$3.8M
Purinergic regulation of T cellsR01GM051477 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JUNGER, WOLFGANG G · 2003 to 2016
$2.5M
Purinergic receptors in inflammationR01AI080582 · NIAID · BETH ISRAEL DEACONESS MEDICAL CENTER · PI JUNGER, WOLFGANG G · 2009 to 2012
$1.4M
Harvard Trauma Inflammation Training ProgramT32GM103702 · NIGMS · BETH ISRAEL DEACONESS MEDICAL CENTER · PI JUNGER, WOLFGANG G · 2013 to 2017
$922k
HYPERTONIC SALINE AND IMMUNE FUNCTIONR29GM051477 · NIGMS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI JUNGER, WOLFGANG G · 1996 to 2000
$116k
NIAID NIH HHS AI-080582NIAID NIH HHS R01 AI080582NIGMS NIH HHS GM-51477NIGMS NIH HHS GM-60475NIGMS NIH HHS R01 GM051477NIGMS NIH HHS R01 GM060475NIGMS NIH HHS R29 GM051477NIGMS NIH HHS T32 GM103702NIGMS NIH HHS T32GM103702
6 · The paper itself

Abstract

T cells play a central role in host defense. ATP release and autocrine feedback via purinergic receptors has been shown to regulate T cell function. However, the sources of the ATP that drives this process are not known. We found that stimulation of T cells triggers a spike in cellular ATP production that doubles intracellular ATP levels in <30 s and causes prolonged ATP release into the extracellular space. Cell stimulation triggered rapid mitochondrial Ca(2+) uptake, increased oxidative phosphorylation, a drop in mitochondrial membrane potential (Δψm), and the accumulation of active mitochondria at the immune synapse of stimulated T cells. Inhibition of mitochondria with CCCP, KCN, or rotenone blocked intracellular ATP production, ATP release, intracellular Ca(2+) signaling, induction of the early activation marker CD69, and IL-2 transcription in response to cell stimulation. These findings demonstrate that rapid activation of mitochondrial ATP production fuels the purinergic signaling mechanisms that regulate T cells and define their role in host defense.

Indexed as

Adenosine TriphosphateAutocrine CommunicationCalcium SignalingCarbonyl Cyanide m-Chlorophenyl HydrazoneCommunicable DiseasesHumansImmunity, CellularImmunosuppression TherapyInflammationMembrane Potential, MitochondrialMitochondriaOxidative PhosphorylationReceptors, PurinergicT-LymphocytesAdenosine TriphosphateCarbonyl Cyanide m-Chlorophenyl HydrazoneReceptors, PurinergicATPCalciumCellular Immune ResponseImmunosuppressionInfectious DiseaseInflammationPurinergic ReceptorPurinergic SignalingT Cell

Identifiers

PMID25070895
PMCPMC4162192
OpenAlexW2028321471

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.